ACRIN Gynecologic Committee

Feb 01, 2026

40 likes | 175 Vues

The ACRIN Gynecologic Committee meeting led by Dr. Susanna I. Lee at Massachusetts General Hospital focused on identifying imaging technologies that could act as prognostic biomarkers in targeted ovarian cancer treatment. The meeting aimed to develop methods for optimizing anatomical and functional targeting in gynecologic cancers. Additionally, discussions included ongoing research trials and their importance to ACRIN's overarching research objectives. Key contributions came from committee members involved in various gynecologic cancer programs and trials.

chesna

Télécharger la présentation

ACRIN Gynecologic Committee

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

ACRIN Gynecologic Committee Fall Meeting 2010 Susanna I Lee, MD, PhD, Chair Massachusetts General Hospital
Learning Objectives • Identify imaging technologies that could serve as prognostic biomarkers in targeted treatment of ovarian cancer. • Develop imaging methods that could serve to optimize anatomically and functionally targeted treatment of gynecologic cancer. • Discuss scientific goals and preliminary results of ongoing gynecologic research trials and their relevance to ACRIN’s overall research goals.
Committee Members Jean Lee Zheng Zhang
NCI Gynecologic Cancer Trials • Cancer Imaging Program • ACRIN • Gynecologic Cancer Program • GOG, SWOG, RTOG • Steering committee • Task forces – Ovary, Uterine corpus, Cervix • Gynecologic Cancer Intergroup